Antimalarial activity of the myxobacterial macrolide chlorotonil A
Myxobacteria are Gram-negative soil-dwelling bacteria belonging to the phylum
Proteobacteria. They are a rich source of promising compounds for clinical application, such …
Proteobacteria. They are a rich source of promising compounds for clinical application, such …
Activity against Plasmodium falciparum of Lactones Isolated from the Endophytic Fungus Xylaria sp.
C Jiménez-Romero, E Ortega-Barría… - Pharmaceutical …, 2008 - Taylor & Francis
Three lactones were isolated from the culture medium of the endophytic fungus Xylaria sp.
Grev.(Xylariaceae). The major compound, which showed weak activity (13 μ g/mL) against a …
Grev.(Xylariaceae). The major compound, which showed weak activity (13 μ g/mL) against a …
Chemobiosynthesis of new antimalarial macrolides
CD Goodman, M Useglio, S Peirú… - Antimicrobial agents …, 2013 - Am Soc Microbiol
We have synthesized new derivatives of the macrolide antibiotics erythromycin and
azithromycin. Novel deoxysugar moieties were attached to these standard antibiotics by …
azithromycin. Novel deoxysugar moieties were attached to these standard antibiotics by …
16-membered macrolide antibiotics: a review
The 16-membered macrolide antibiotics (eg tylosin A and josamycin) are mainly used in
veterinary medicine, and are much less studied than their 14-and 15-membered …
veterinary medicine, and are much less studied than their 14-and 15-membered …
In vitro and in vivo antimalarial activities of a non-glycosidic 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia
K Otoguro, H Ui, A Ishiyama, M Kobayashi… - The Journal of …, 2003 - jstage.jst.go.jp
In the course of our screening program to discover antimalarial antibiotics from soil
microorganisms which are active against drug-resistant parasites in vitro and in vivo, we …
microorganisms which are active against drug-resistant parasites in vitro and in vivo, we …
Targeting the human malaria parasite Plasmodium falciparum: In vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline series
C Castera-Ducros, N Azas, P Verhaeghe… - European journal of …, 2011 - Elsevier
From the promising results we previously obtained in quinazoline series and to complete the
evaluation of the in vitro antiplasmodial activity of original 2-trichloromethylquinazolines, we …
evaluation of the in vitro antiplasmodial activity of original 2-trichloromethylquinazolines, we …
Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine …
BR Dos Santos, ABSB Ramos, RPB de Menezes… - PloS one, 2023 - journals.plos.org
Toxoplasmosis, caused by the obligate intracellular parasite Toxoplasma gondii, affects
about one-third of the world's population and can cause severe congenital, neurological and …
about one-third of the world's population and can cause severe congenital, neurological and …
Clinical evaluation of moxalactam
GE Mathisen, RD Meyer, JM Thompson… - Antimicrobial Agents …, 1982 - Am Soc Microbiol
Moxalactam was administered intravenously or intramuscularly or both in doses of 1 to 12
g/day to 45 patients with clinically significant infections (17 soft tissue or bone, 9 …
g/day to 45 patients with clinically significant infections (17 soft tissue or bone, 9 …
Moxalactam (latamoxef) a review of its antibacterial activity, pharmacokinetic properties and therapeutic use
AA Carmine, RN Brogden, RC Heel, JA Romankiewicz… - Drugs, 1983 - Springer
Summary Synopsis: Moxalactam 1 (latamoxef) is a new synthetic oxa-β-lactam antibiotic
administered intravenously or intramuscularly. It has a broad spectrum of activity against …
administered intravenously or intramuscularly. It has a broad spectrum of activity against …
In Vitro and In Vivo Activity of Solithromycin (CEM-101) against Plasmodium Species
S Wittlin, E Ekland, JC Craft, J Lotharius… - Antimicrobial agents …, 2012 - Am Soc Microbiol
With the emergence of Plasmodium falciparum infections exhibiting increased parasite
clearance times in response to treatment with artemisinin-based combination therapies, the …
clearance times in response to treatment with artemisinin-based combination therapies, the …